ARCT — Arcturus Therapeutics Holdings Inc · rev $5.0M

Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.

Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.

Use this ARCT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ARCT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ARCT SEC filings page. Lician reads the product cache first so this HTML stays unique to Arcturus Therapeutics Holdings Inc even when a live quote feed is slow.

Arcturus Therapeutics Holdings Inc latest statements (FY2025)

Latest cached year on this hub. Full ARCT income, balance, and cash tables.

  • Revenue$82.0M
  • Net Income-$65.8M
  • Total Assets$271.1M
  • Total Debt$0
  • Free Cash Flow-$74.5M

ARCT recent filings